Latest Share Chat

REMOVE ADS

Hutchmed Share News (HCM)

Hutchmed Information

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes

Get Live Data

168.00 3.25 (1.97%)

Bid:

158.50

Ask:

167.50

Spread: 9.00 (5.678%)

Market Cap: £1.44b

Last checked at -

Intraday Hutchmed Share Chart

REMOVE ADS

Hutchmed News

Hutchmed to present new and updated clinical trial data

(Sharecast News) - Hutchmed China has announced that it would present new and updated clinical trial data at two major oncology conferences - the 2024...

Hutchmed "disappointed" as it withdraws fruquintinib application

(Alliance News) - Hutchmed (China) Ltd announced on Friday that it has voluntarily withdrawn its supplemental new drug application for fruquintinib in...

Hutchmed withdraws supplemental new drug application in China

(Sharecast News) - Hutchmed China has voluntarily withdrawn its supplemental new drug application (NDA) in China for the use of fruquintinib in combin...

Hutchmed confident of full year guidance for oncology and immunology

(Alliance News) - Hutchmed (China) Limited on Wednesday said it remains on track to meet full year guidance for its oncology/immunology business, desp...

Oncology revenue drives first-half growth for Hutchmed

(Sharecast News) - Hutchmed China reported a robust set of first-half financial results on Wednesday, underpinned by significant growth in oncology pr...

UK earnings, trading statements calendar - next 7 days

IN BRIEF: Hutchmed's tazemetostat given priority review in China

Hutchmed (China) Ltd - Hong Kong-based pharmaceutical company - Says new drug application for tazemetostat given priority review by the China National...

Hutchmed gets tazemetostat new drug application approved in China

(Sharecast News) - Hutchmed China announced on Thursday that the China National Medical Products Administration (NMPA) has accepted its new drug appli...